Found: 43
Select item for more details and to access through your institution.
Seroprevalence of SARS-CoV-2 among Blood Donors and Changes after Introduction of Public Health and Social Measures, London, UK.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Incidence of influenza A(H1N1)pdm09 infection, United Kingdom, 2009-2011.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Incidence of Influenza A(H1N1) pdm09 Infection, United Kingdom, 2009-2011.
- Published in:
- Emerging Infectious Diseases, 2013, v. 19, n. 11, p. 1866, doi. 10.3201/eid1911.130295
- By:
- Publication type:
- Article
Seroprevalence of Influenza A(H1N1)pdm09 Virus Antibody, England, 2010 and 2011.
- Published in:
- Emerging Infectious Diseases, 2012, v. 18, n. 11, p. 1894, doi. 10.3201/eid1811.120720
- By:
- Publication type:
- Article
Seroepidemiologic Study of Pandemic (H1N1) 2009 during Outbreak in Boarding School, England.
- Published in:
- Emerging Infectious Diseases, 2011, v. 17, n. 9, p. 1670, doi. 10.3201/eid1709.100761
- By:
- Publication type:
- Article
Reproducibility of Serologic Assays for Influenza Virus A (H5N1).
- Published in:
- Emerging Infectious Diseases, 2009, v. 15, n. 8, p. 1250, doi. 10.3201/eid1508.081754
- By:
- Publication type:
- Article
A case of swine influenza A(H1N2)v in England, November 2023.
- Published in:
- Eurosurveillance (15607917), 2024, v. 29, n. 3, p. 2, doi. 10.2807/1560-7917.ES.2024.29.3.2400002
- By:
- Publication type:
- Article
High attack rate in a large care home outbreak of SARS-CoV-2 BA.2.86, East of England, August 2023.
- Published in:
- Eurosurveillance (15607917), 2023, v. 28, n. 39, p. 7, doi. 10.2807/1560-7917.ES.2023.28.39.2300489
- By:
- Publication type:
- Article
Robust antibody responses in 70-80-year-olds 3 weeks after the first or second doses of Pfizer/BioNTech COVID-19 vaccine, United Kingdom, January to February 2021.
- Published in:
- Eurosurveillance (15607917), 2021, v. 26, n. 12, p. 2, doi. 10.2807/1560-7917.ES.2021.26.12.2100329
- By:
- Publication type:
- Article
Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020.
- Published in:
- Eurosurveillance (15607917), 2021, v. 26, n. 5, p. 8, doi. 10.2807/1560-7917.ES.2021.26.5.2100092
- By:
- Publication type:
- Article
End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18.
- Published in:
- Eurosurveillance (15607917), 2019, v. 24, n. 31, p. 23, doi. 10.2807/1560-7917.ES.2019.24.31.1800488
- By:
- Publication type:
- Article
End of 2022/23 Season Influenza Vaccine Effectiveness in Primary Care in Great Britain.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 5, p. 1, doi. 10.1111/irv.13295
- By:
- Publication type:
- Article
Interim 2023/2024 Season Influenza Vaccine Effectiveness in Primary and Secondary Care in the United Kingdom.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 5, p. 1, doi. 10.1111/irv.13284
- By:
- Publication type:
- Article
Monoclonal antibodies to the haemagglutinin HA1 subunit of the pandemic influenza A/H1N1 2009 virus and potential application to serodiagnosis.
- Published in:
- Journal of Medical Virology, 2011, v. 83, n. 4, p. 559, doi. 10.1002/jmv.21982
- By:
- Publication type:
- Article
Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.909297
- By:
- Publication type:
- Article
Cellular immune correlates of protection against symptomatic pandemic influenza.
- Published in:
- Nature Medicine, 2013, v. 19, n. 10, p. 1305, doi. 10.1038/nm.3350
- By:
- Publication type:
- Article
Early mucosal events promote distinct mucosal and systemic antibody responses to live attenuated influenza vaccine.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-43842-7
- By:
- Publication type:
- Article
Matrix M H5N1 Vaccine Induces Cross-H5 Clade Humoral Immune Responses in a Randomized Clinical Trial and Provides Protection from Highly Pathogenic Influenza Challenge in Ferrets.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0131652
- By:
- Publication type:
- Article
Comparing the Immunogenicity of AS03-Adjuvanted 2009 Pandemic H1N1 Vaccine with Clinical Protection in Priority Risk Groups in England.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0056844
- By:
- Publication type:
- Article
Multi-Centre Observational Study of Transplacental Transmission of Influenza Antibodies following Vaccination with AS03<sub>A</sub>-Adjuvanted H1N1 2009 Vaccine.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0047448
- By:
- Publication type:
- Article
Age-Specific Incidence of A/H1N1 2009 Influenza Infection in England from Sequential Antibody Prevalence Data Using Likelihood-Based Estimation.
- Published in:
- PLoS ONE, 2011, v. 6, n. 2, p. 1, doi. 10.1371/journal.pone.0017074
- By:
- Publication type:
- Article
T-Helper 1 Cells Elicited by H5N1 Vaccination Predict Seroprotection.
- Published in:
- Journal of Infectious Diseases, 2012, v. 206, n. 2, p. 158, doi. 10.1093/infdis/jis330
- By:
- Publication type:
- Article
Coadministration of Seasonal Influenza Vaccine and MVA-NP+M1 Simultaneously Achieves Potent Humoral and Cell-Mediated Responses.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 1, p. 233, doi. 10.1038/mt.2013.162
- By:
- Publication type:
- Article
Responses to Quadrivalent Influenza Vaccine Reveal Distinct Circulating CD4+CXCR5+ T Cell Subsets in Men Living with HIV.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-51961-9
- By:
- Publication type:
- Article
Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1155552
- By:
- Publication type:
- Article
An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1129765
- By:
- Publication type:
- Article
Viral Shedding in Recipients of Live Attenuated Influenza Vaccine in the 2016–2017 and 2017–2018 Influenza Seasons in the United Kingdom.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 12, p. 2505, doi. 10.1093/cid/ciz719
- By:
- Publication type:
- Article
Complexities in Predicting the Immunogenicity of Live Attenuated Influenza Vaccines.
- Published in:
- Clinical Infectious Diseases, 2020, v. 79, n. 10, p. 2235, doi. 10.1093/cid/ciz773
- By:
- Publication type:
- Article
A Double-Blind, Randomized Trial of High-Dose vs Standard-Dose Influenza Vaccine in Adult Solid-Organ Transplant Recipients.
- Published in:
- Clinical Infectious Diseases, 2018, v. 66, n. 11, p. 1698, doi. 10.1093/cid/cix1082
- By:
- Publication type:
- Article
Administration of AS03B-adjuvanted A(H1N1)pdm09 Vaccine in Children Aged <3 Years Enhances Antibody Response to H3 and B Viruses Following a Single Dose of Trivalent Vaccine One Year Later.
- Published in:
- Clinical Infectious Diseases, 2014, v. 58, n. 2, p. 181, doi. 10.1093/cid/cit692
- By:
- Publication type:
- Article
Longevity and Determinants of Protective Humoral Immunity after Pandemic Influenza Infection.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2015, v. 191, n. 3, p. 325, doi. 10.1164/rccm.201410-1798OC
- By:
- Publication type:
- Article
Inactivated pandemic 2009 H1N1 influenza A virus human vaccines have different efficacy after homologous challenge in the ferret model.
- Published in:
- Influenza & Other Respiratory Viruses, 2021, v. 15, n. 1, p. 142, doi. 10.1111/irv.12784
- By:
- Publication type:
- Article
International flight-related transmission of pandemic influenza A( H1 N1)pdm09: an historical cohort study of the first identified cases in the United Kingdom.
- Published in:
- Influenza & Other Respiratory Viruses, 2014, v. 8, n. 1, p. 66, doi. 10.1111/irv.12181
- By:
- Publication type:
- Article
Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting.
- Published in:
- Influenza & Other Respiratory Viruses, 2013, v. 7, n. 2, p. 211, doi. 10.1111/j.1750-2659.2012.0370a.x
- By:
- Publication type:
- Article
Cross-neutralisation of antibodies elicited by an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine in healthy adults against H5N1 clade 2 strains.
- Published in:
- Influenza & Other Respiratory Viruses, 2007, v. 1, n. 5/6, p. 199, doi. 10.1111/j.1750-2659.2007.00033.x
- By:
- Publication type:
- Article
A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies.
- Published in:
- Influenza & Other Respiratory Viruses, 2007, v. 1, n. 3, p. 105, doi. 10.1111/j.1750-2659.2007.00016.x
- By:
- Publication type:
- Article
A Haemophilus sp. dominates the microbiota of sputum from UK adults with non-severe community acquired pneumonia and chronic lung disease.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-38090-5
- By:
- Publication type:
- Article
Estimation of Seasonal Influenza Attack Rates and Antibody Dynamics in Children Using Cross-Sectional Serological Data.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cell-Mediated Immune Responses After Influenza Vaccination of Solid Organ Transplant Recipients: Secondary Outcomes Analyses of a Randomized Controlled Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Forecasting the 2017/2018 seasonal influenza epidemic in England using multiple dynamic transmission models: a case study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
H1N1 Antibody Persistence 1 Year After Immunization With an Adjuvanted or Whole-Virion Pandemic Vaccine and Immunogenicity and Reactogenicity of Subsequent Seasonal Influenza Vaccine: A Multicenter Follow-on Study.
- Published in:
- Clinical Infectious Diseases, 2012, v. 54, n. 5, p. 661, doi. 10.1093/cid/cir905
- By:
- Publication type:
- Article
Humoral Response to the Influenza A H1N1/09 Monovalent AS03-Adjuvanted Vaccine in Immunocompromised Patients.
- Published in:
- Clinical Infectious Diseases, 2011, v. 52, n. 2, p. 248, doi. 10.1093/cid/ciq104
- By:
- Publication type:
- Article
Immunogenicity of Pandemic (H1N1) 2009 Vaccine in Children with Cancer in the United Kingdom.
- Published in:
- Clinical Infectious Diseases, 2010, v. 51, n. 12, p. e95, doi. 10.1086/657403
- By:
- Publication type:
- Article